Supernus Pharmaceuticals Inc. (0LB2)
Market Closed
17 Jul, 15:30
LSE 
$
48. 33
+0.85
+1.7902%
$
- Market Cap
64.88 P/E Ratio
- Div Yield
9 Volume
2.16 Eps
$ 47.48
Previous Close Want to track 0LB2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
0LB2 Earnings Reports FAQ
What is the earnings per share (EPS) for 0LB2?
The current EPS is 2.16.
What is the company's earnings growth rate?
Supernus Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Supernus Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Supernus Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 0LB2 at this time, as Supernus Pharmaceuticals Inc has no recent EPS data to calculate it.
